Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $384,012 - $432,269
-4,745 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$70.67 - $99.01 $10,600 - $14,851
150 Added 3.26%
4,745 $391,000
Q4 2019

Feb 10, 2020

BUY
$84.35 - $95.37 $14,761 - $16,689
175 Added 3.96%
4,595 $435,000
Q3 2019

Nov 12, 2019

SELL
$85.54 - $94.26 $33,360 - $36,761
-390 Reduced 8.11%
4,420 $384,000
Q2 2019

Aug 09, 2019

BUY
$75.4 - $92.8 $6,786 - $8,352
90 Added 1.91%
4,810 $439,000
Q1 2019

May 13, 2019

SELL
$75.32 - $86.15 $2,259 - $2,584
-30 Reduced 0.63%
4,720 $454,000
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $27,990 - $31,167
-380 Reduced 7.41%
4,750 $408,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $104,426 - $120,790
1,560 Added 43.7%
5,130 $442,000
Q2 2018

Aug 08, 2018

SELL
$64.91 - $73.36 $115,215 - $130,214
-1,775 Reduced 33.21%
3,570 $270,000
Q4 2017

Feb 13, 2018

BUY
$72.33 - $77.64 $386,603 - $414,985
5,345
5,345 $449,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $236B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Poehling Capital Management, Inc. Portfolio

Follow Poehling Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.